Multiple Sclerosis (MS) Drugs

| Avonex | Betaseron | Betaferon | Copaxone | Rebif |

 

Avonex ®  Unknowns (interferon beta-1a)

Safety and Efficacy (Effectiveness)

Safety and efficacy (effectiveness) of treatment with Avonex ® beyond 3 years is not known.

The safety and efficacy (effectiveness) of Avonex ® in patients with chronic progressive multiple sclerosis have not been established.

The safety and efficacy (effectiveness) of Avonex ® in pediatric patients under the age of 18 years have not been evaluated.

Study numbers of patients over the age of 65 years were insufficient to draw conclusions as to whether they responded differently to Avonex ® than younger patients.

It is unknown whether Avonex ® can affect human reproductive capacity.

 

 

 

Multiple Sclerosis

Approx 2.5 million people worldwide, have Multiple Sclerosis.

Cause of Multiple Sclerosis

The cause of multiple sclerosis remains a mystery. Many different causes have been proposed and investigated but as yet the cause of multiple sclerosis remains elusive... Read More